Clinical Trials in Ohio

Showing 17421-17440 of 20,938 trials

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

NCT00107536

Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well lapatinib ditosylate works in treating patients with unresectable liver or biliary tract cancer

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more

National Cancer Institute (NCI)26 participantsStarted Oct 2005

Columbus, Ohio, United States

COMPLETED32 miles

Community Awareness, Resources and Education (CARE I): Project 3

NCT02113514

Community Awareness, Resources and Education (CARE) Project - Project 3 will determine if Appalachian women have unique risk factors for an abnormal Pap smear that might contribute to the increased risk of cervical abnormalities, specifically cancer, in their communities.

Cervical Abnormality

Ohio State University Comprehensive Cancer Center2,394 participantsStarted May 2005

Ann Arbor, Michigan, United States • Columbus, Ohio, United States

COMPLETEDPhase 332 miles

A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study

NCT01626742

Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients.

Hospitalized Elderly

Abbott Nutrition652 participantsStarted May 2012

Auburn, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +116 more locations

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Community Awareness, Resources and Education (CARE I): Project 3

A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study

Find Trials by Condition in Ohio

Functional MRI in Lupus Nephritis

Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes

Green Tea Anticancer Mechanisms in Smokers

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial

CSP #512 - Options in Management With Anti-Retrovirals

ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)

Patient-Centered Adherence Intervention After Acute Coronary Syndrome (ACS) Hospitalization

Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

Re-Engineering Systems for the Primary Care Treatment for PTSD

Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)